Covid-19

New Study Provides More Evidence Hydroxychloroquine Can't Treat COVID-19

Per previous studies, the anti-malaria drug hydroxychloroquine has been touted as a supposed miracle cure for COVID-19, the sickness behind the current coronavirus pandemic. Newer studies, however, say otherwise, stating that using it would make patients fare no better than they do if they undergo standard care.

Evidence Points Hydroxychloroquine Can’t Cure COVID-19

In the past month, research around the anti-malaria drug hydroxychloroquine states that it has the potential to be the COVID-19 cure that we are looking for. As such, it’s been touted by many, including U.S. President Donald Trump, as a miracle cure for COVID-19. Newer research, however, is saying otherwise.

As per six studies examined by a team of researchers in Iran (as well as a few choice studies from both China and France), using the drug can’t actually shorten the recovery time. In fact, when compared to standard care, which usually includes oxygen, fluids, monitoring and other supportive care, there is no relevant difference in outcomes. The findings of the research were published Apr. 20 on medRxiv.org.

However, since COVID-19 is a respiratory disease that targets our lungs, additional examinations were made. Per the results, there are slightly more people that took the drugs and showed clearer lungs compared with those that are on standard treatment. Furthermore, the virus’ genetic material was also detectable in slightly fewer people than those who didn’t take it at all. However, there were also some mild side effects, such as headaches and rashes. Following this, the team behind the research said that they have far too few patients to provide a definitive conclusion.

Meanwhile, researchers in South Carolina that examined record of 368 male COVID patients revealed that taking the drug showed no effect, either alone or in combination with azithromycin to treat the disease, especially when compared to standard care.

There’s a reason as to why these studies have been made, however, since hydroxychloroquine did stop the coronavirus from infecting the cells of monkey test subjects during a medical trial. And since the drug is used to treat people with autoimmune conditions, they hoped it would work on the coronavirus as well.

Coronavirus COVID-19 Laboratory Test, Cure, Vaccine Andressa Parreiras, Biomedic, and Larissa Vuitika, biologist, work in a laboratory during the extraction of the virus genetic material on March 24, 2020 in Belo Horizonte, Brazil. The Ministry of Health convened The Technological Vaccine Center of the Federal University of Minas Gerais laboratory to conduct research on the coronavirus (COVID-19) in order to diagnose, test and develop a vaccine. According to the Ministry of Health, as of Tuesday, March 24, Brazil has 1.891 confirmed cases of the coronavirus (COVID-19) and at least 34 recorded deceases. Pedro Vilela/Getty Images

Loading...